Approximately 44% of homeless adults are hepatitis C virus (HCV)-infected. Historically, homeless and marginally housed (HMH) adults have faced barriers to HCV treatment. New, interferon-free therapies have excellent cure rates and improved tolerability, reducing barriers for treatment. To our knowledge, no published studies have documented the treatment of HMH populations with these therapies.The Boston Health Care for the Homeless Program (BHCHP) began treating HMH adults with oral agents in 2014.
Boston Health Care for the Homeless Program receives HHS funding and has Federal PHS deemed status with respect to certain health or health-related claims, including medical malpractice claims, for itself and its covered individuals.
780 Albany Street
Boston, MA 02118
Sign up for BHCHP updates